AUD 0.26
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | 6.97 Million AUD | -9.38% |
2023 | 9.46 Million AUD | 44.56% |
2022 | 6.54 Million AUD | 12.51% |
2021 | 5.82 Million AUD | 21.28% |
2020 | 4.79 Million AUD | 201.26% |
2019 | 1.59 Million AUD | -15.76% |
2018 | 1.89 Million AUD | 164.48% |
2017 | 715 Thousand AUD | -72.25% |
2016 | 2.57 Million AUD | 28.72% |
2015 | 2 Million AUD | -0.74% |
2014 | 2.01 Million AUD | -13.77% |
2013 | 2.33 Million AUD | 12.34% |
2012 | 2.08 Million AUD | -24.32% |
2011 | 2.75 Million AUD | 41.51% |
2010 | 1.94 Million AUD | -22.27% |
2009 | 2.5 Million AUD | -9.42% |
2008 | 2.76 Million AUD | -19.92% |
2007 | 3.44 Million AUD | -46.49% |
2006 | 6.44 Million AUD | 8.56% |
2005 | 5.93 Million AUD | 48.18% |
2004 | 4 Million AUD | -23.51% |
2003 | 5.23 Million AUD | -37.73% |
2002 | 8.41 Million AUD | 450.75% |
2001 | 1.52 Million AUD | -9.16% |
2000 | 1.68 Million AUD | 0.0% |
1999 | - AUD | 0.0% |
1998 | - AUD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 9.22 Million AUD | 0.0% |
2024 FY | 8.56 Million AUD | -9.52% |
2024 Q4 | 6.97 Million AUD | 0.0% |
2023 Q4 | 9.46 Million AUD | 0.0% |
2023 FY | 9.46 Million AUD | 44.56% |
2023 Q2 | 9.81 Million AUD | 0.0% |
2022 Q4 | 6.54 Million AUD | 0.0% |
2022 FY | 6.54 Million AUD | 12.51% |
2022 Q2 | 7.34 Million AUD | 0.0% |
2021 FY | 5.82 Million AUD | 21.28% |
2021 Q4 | 5.82 Million AUD | 0.0% |
2021 Q2 | 4.98 Million AUD | 0.0% |
2020 FY | 4.79 Million AUD | 201.26% |
2020 Q2 | 3.96 Million AUD | 0.0% |
2020 Q4 | 4.79 Million AUD | 0.0% |
2019 FY | 1.59 Million AUD | -15.76% |
2019 Q2 | 1.81 Million AUD | 0.0% |
2019 Q4 | 1.59 Million AUD | 0.0% |
2018 FY | 1.89 Million AUD | 164.48% |
2018 Q2 | 831 Thousand AUD | 0.0% |
2018 Q4 | 1.89 Million AUD | 0.0% |
2017 Q4 | 715 Thousand AUD | 0.0% |
2017 FY | 715 Thousand AUD | -72.25% |
2017 Q2 | 983 Thousand AUD | 0.0% |
2016 Q4 | 2.57 Million AUD | 0.0% |
2016 FY | 2.57 Million AUD | 28.72% |
2016 Q2 | 1.86 Million AUD | 0.0% |
2015 FY | 2 Million AUD | -0.74% |
2015 Q4 | 2 Million AUD | 0.0% |
2015 Q2 | 2.53 Million AUD | 0.0% |
2014 FY | 2.01 Million AUD | -13.77% |
2014 Q2 | 1.99 Million AUD | 0.0% |
2014 Q4 | 2.01 Million AUD | 0.0% |
2013 Q2 | - AUD | 0.0% |
2013 FY | 2.33 Million AUD | 12.34% |
2013 Q4 | 2.33 Million AUD | 0.0% |
2012 FY | 2.08 Million AUD | -24.32% |
2012 Q4 | 2.08 Million AUD | 0.0% |
2011 FY | 2.75 Million AUD | 41.51% |
2011 Q4 | 2.75 Million AUD | 0.0% |
2010 FY | 1.94 Million AUD | -22.27% |
2010 Q4 | 1.94 Million AUD | 0.0% |
2009 FY | 2.5 Million AUD | -9.42% |
2009 Q4 | 2.5 Million AUD | 0.0% |
2008 FY | 2.76 Million AUD | -19.92% |
2008 Q4 | 2.76 Million AUD | 0.0% |
2007 FY | 3.44 Million AUD | -46.49% |
2007 Q4 | 3.4 Million AUD | 0.0% |
2006 FY | 6.44 Million AUD | 8.56% |
2006 Q4 | 6.44 Million AUD | 0.0% |
2005 Q4 | 5.97 Million AUD | 0.0% |
2005 FY | 5.93 Million AUD | 48.18% |
2004 Q4 | 4.05 Million AUD | 0.0% |
2004 FY | 4 Million AUD | -23.51% |
2003 Q4 | 5.23 Million AUD | 0.0% |
2003 FY | 5.23 Million AUD | -37.73% |
2002 FY | 8.41 Million AUD | 450.75% |
2002 Q4 | 8.41 Million AUD | 0.0% |
2001 FY | 1.52 Million AUD | -9.16% |
2001 Q4 | 1.37 Million AUD | 0.0% |
2000 FY | 1.68 Million AUD | 0.0% |
1999 FY | - AUD | 0.0% |
1998 FY | - AUD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
4DMedical Limited | 5.12 Million AUD | -36.253% |
Adherium Limited | 93.2 Thousand AUD | -7385.65% |
Aroa Biosurgery Limited | 6.81 Million AUD | -2.351% |
Atomo Diagnostics Limited | 84.67 Thousand AUD | -8140.227% |
Anteris Technologies Ltd | 2.33 Million AUD | -199.069% |
Control Bionics Limited | 961.73 Thousand AUD | -625.457% |
CardieX Limited | 3.22 Million AUD | -116.157% |
Cochlear Limited | 243.7 Million AUD | 97.137% |
CleanSpace Holdings Limited | 3.44 Million AUD | -102.449% |
Cyclopharm Limited | 4.22 Million AUD | -65.046% |
EMVision Medical Devices Ltd | 2.9 Million AUD | -140.561% |
Nova Eye Medical Limited | 3.34 Million AUD | -108.331% |
HeraMED Limited | 260.65 Thousand AUD | -2576.708% |
Imricor Medical Systems, Inc. | 15.7 Million AUD | 55.565% |
ImpediMed Limited | 1.14 Million AUD | -510.411% |
InhaleRx Limited | 560.27 Thousand AUD | -1145.281% |
LBT Innovations Limited | 1.74 Million AUD | -300.287% |
Micro-X Limited | 4.05 Million AUD | -72.059% |
Neurotech International Limited | - AUD | -Infinity% |
OncoSil Medical Limited | 70.67 Thousand AUD | -9772.368% |
PolyNovo Limited | 15.38 Million AUD | 54.636% |
Respiri Limited | 1.17 Million AUD | -492.998% |
SomnoMed Limited | 1.01 Million AUD | -586.704% |
Universal Biosensors, Inc. | 4.97 Million AUD | -40.34% |
Uscom Limited | 989.27 Thousand AUD | -605.262% |
Visioneering Technologies, Inc. | 312.15 Thousand AUD | -2135.1% |